Abstract

Mucormycosis is a life-threatening respiratory fungal infection predominantly caused by Rhizopus species. Mucormycosis has incompletely understood pathogenesis, particularly how abnormalities in iron metabolism compromise immune responses. Here we show how, as opposed to other filamentous fungi, Rhizopus spp. establish intracellular persistence inside alveolar macrophages (AMs). Mechanistically, lack of intracellular swelling of Rhizopus conidia results in surface retention of melanin, which induces phagosome maturation arrest through inhibition of LC3-associated phagocytosis. Intracellular inhibition of Rhizopus is an important effector mechanism, as infection of immunocompetent mice with swollen conidia, which evade phagocytosis, results in acute lethality. Concordantly, AM depletion markedly increases susceptibility to mucormycosis. Host and pathogen transcriptomics, iron supplementation studies, and genetic manipulation of iron assimilation of fungal pathways demonstrate that iron restriction inside macrophages regulates immunity against Rhizopus. Our findings shed light on the pathogenetic mechanisms of mucormycosis and reveal the role of macrophage-mediated nutritional immunity against filamentous fungi.

Details

Title
Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species
Author
Andrianaki, Angeliki M 1 ; Kyrmizi, Irene 2 ; Thanopoulou, Kalliopi 3 ; Baldin, Clara 4 ; Drakos, Elias 1 ; Soliman, Sameh S M 5 ; Shetty, Amol C 6 ; McCracken, Carrie 6 ; Akoumianaki, Tonia 1 ; Stylianou, Kostas 1 ; Ioannou, Petros 1   VIAFID ORCID Logo  ; Pontikoglou, Charalampos 1 ; Papadaki, Helen A 1 ; Tzardi, Maria 1 ; Belle, Valerie 7 ; Etienne, Emilien 7 ; Beauvais, Anne 8 ; Samonis, George 1 ; Kontoyiannis, Dimitrios P 9 ; Andreakos, Evangelos 3 ; Bruno, Vincent M 6 ; Ibrahim, Ashraf S 10 ; Chamilos, Georgios 2   VIAFID ORCID Logo 

 Department of Medicine, University of Crete, Foundation for Research and Technology, Heraklion, Crete, Greece 
 Department of Medicine, University of Crete, Foundation for Research and Technology, Heraklion, Crete, Greece; Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Crete, Greece 
 Laboratory of Immunobiology, Center for Clinical, Experimental Surgery, and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece 
 Division of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, CA, USA 
 Sharjah Institute for Medical Research, College of Pharmacy, University of Sharjah, Sharjah, UAE 
 Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA 
 CNRS, BIP (UMR 7281), IMM (FR 3479), Aix-Marseille Université, Marseille, France 
 Unité des Aspergillus, Institut Pasteur, Paris, France 
 Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 
10  Division of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, CA, USA; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA 
Pages
1-17
Publication year
2018
Publication date
Aug 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2090284460
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.